Kathleen Minton
Psychiatric/Mental Health · Anthony, NMNPI 1548617566
Payments from drug & device makers
Across 29 payments — averaging $28.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$380
- Vanda Pharmaceuticals Inc.$166
- Teva Pharmaceuticals USA, Inc.$108
- Otsuka America Pharmaceutical, Inc.$62
- Lundbeck LLC$33
- Axsome Therapeutics, Inc.$25
- plus $57 from 3 others
What the payments were for
- Food & beverage$830100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $380 |
| Vanda Pharmaceuticals Inc. | 3 | $166 |
| Teva Pharmaceuticals USA, Inc. | 2 | $108 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Lundbeck LLC | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Alkermes, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$830 in reported general payments places this provider in the 70th percentile of 228 psychiatric/mental health providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 73 | $115,886 |
| IngrezzaValbenazine Tosylate | 11 | $101,457 |
| Invega SustennaPaliperidone Palmitate | 13 | $40,526 |
| VraylarCariprazine Hcl | 17 | $25,349 |
| TrintellixVortioxetine Hydrobromide | 15 | $7,421 |
| Buspirone Hcl | 74 | $1,141 |
| Duloxetine Hcl | 36 | $715 |
| Mirtazapine | 47 | $652 |
| Fluoxetine Hcl | 70 | $576 |
| Memantine Hcl | 15 | $527 |
| Bupropion XlBupropion Hcl | 25 | $478 |
| Sertraline Hcl | 43 | $466 |
| Trazodone Hcl | 76 | $343 |
| Escitalopram Oxalate | 51 | $317 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $314 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $62 | $115,88673 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $24 | $101,45711 claims |
| Johnson & JohnsonInvega Sustenna | $13 | $40,52613 claims |
| AbbVieVraylar | $380 | $25,34917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 228 psychiatric/mental health providers in New Mexico.
Other psychiatric/mental health in Anthony
- Valerie AcostaAnthony$831
- Ayanna WilliamsRoswell$23K
- Martha SnowAlbuquerque$13K
- Rachel JoyceSanta Fe$13K
- Vernon OsbornGallup$12K
- Jacqueline TutonLas Cruces$10K
- Jimmy CalzadoRio Rancho$9K
- Mario HerreraLas Cruces$7K
- Heidi PattarozziLas Cruces$6K
- Lorena GarciaLas Cruces$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.